Skip to main content

Table 4 Burden of chronic disease among the newly sick-listed compared to the general population sample #

From: Cumulative incidence of sickness absence and disease burden among the newly sick-listed, a cross-sectional population-based study

 

Standardized by age groups

Standardized by age and socio-economic groups

Standardized by age, socio-economic groups and gender

 

Men

Women

Men

Women

Total sample

 

Expected number of cases

Observed number of cases

Standardized incidence ratio (95% C.I)

Expected number of cases

Observed number of cases

Standardized incidence ratio (95% C.I)

Expected number of cases

Observed number of cases

Standardized incidence ratio (95% C.I)

Expected number of cases

Observed number of cases

Standardized incidence ratio (95% C.I)

Expected number of cases

Observed number of cases

Standardized incidence ratio (95% C.I)

Neoplastic

9

34

4.0 (2.7–5.3)*

20

87

4.3 (3.4–5.2)*

8

33

4.2 (2.8–5.6)*

20

85

4.3 (3.4–5.2)*

1491

977

0.7 (0.6–0.7)*

Endocrine

41

59

1.4 (1.1–1.8)*

120

174

1.5 (1.2–1.7)*

38

58

1.5 (1.2–1.9)*

118

174

1.5 (1.3–1.7)*

314

403

1.3 (1.2–1.4)*

Psychiatric

44

90

2.0 (1.6–2.4)*

148

243

1.6 (1.5–1.8)*

41

87

2.1 (1.7–2.6)*

140

241

1.7 (1.5–1.9)*

386

406

1.1 (1.0–1.1)*

Neurologic

27

44

1.6 (1.2–2.1)*

73

92

1.3 (1.0–1.5)

26

42

1.6 (1.1–2.1)*

70

92

1.3 (1.1–1.6)*

297

311

1.0 (0.9–1.2)

Cardiovascular

130

180

1.4 (1.2–1.6)*

184

223

1.2 (1.1–1.4)*

124

173

1.4 (1.2–1.6)*

180

221

1.2 (1.1–1.4)*

642

851

1.3 (1.2–1.4)*

Pulmonary

109

112

1.0(0.9–1.2)

278

294

1.1 (0.9–1.2)

108

110

1.0 (0.8–1.2)

274

293

1.1 (1.0–1.2)

108

169

1.6 (1.3–1.8)*

Gastrointestinal

87

135

1.5 (1.3–1.8)*

255

328

1.3 (1.2–1.4)*

81

131

1.6 (1.4–1.9)*

249

325

1.3 (1.2–1.4)*

100

136

1.4 (1.1–1.6)*

Skin and allergic

76

87

1.1 (0.9–1.4)

221

224

1.0 (0.9–1.1)

72

84

1.2 (0.9–1.4)

223

222

1.0 (0.9–1.1)

192

333

1.7 (1.6–1.9)*

Musculoskeletal

174

231

1.3 (1.2–1.5)*

467

620

1.3 (1.2–1.4)*

166

228

1.4 (1.2–1.5)*

456

615

1.3 (1.3–1.4)*

161

233

1.4 (1.3–1.6)*

Rheumatic

17

30

1.7 (1.1–2.4)*

91

139

1.5 (1.3–1.8)*

17

30

1.8 (1.2–2.4)*

83

139

1.7 (1.4–2.0)*

29

121

4.2 (3.5–4.9)*

Gynaecologic

–

–

–

80

106

1.3 (1.1–1.6)*

–

–

–

79

105

1.3 (1.1–1.6)*

343

463

1.4 (1.2–1.5)*

Other

32

56

1.7 (1.3–2.2)*

57

71

1.2 (1.0–1.5)

32

54

1.7 (1.2–2.1)*

55

70

1.3 (1.0–1.6)

80

106

1.3 (1.1–1.6)*

No Disease

552

356

0.6 (0.6–0.7)

939

621

0.7 (0.6–0.7)

542

347

0.6 (0.6–0.7)

940

613

0.7 (0.6–0.7)

1563

977

0.6 (0.6–0.7)*

One chronic disease

364

480

1.2 (1.2–1.4)*

696

806

1.2 (1.1–1.2)*

357

469

1.3 (1.2–1.4)*

683

795

1.2 (1.1–1.2)*

1033

1286

1.2 (1.2–1.3)*

More than one chronic disease

157

237

1.5 (1.3–1.7)*

496

704

1.4 (1.3–1.5)*

150

230

1.5 (1.4–1.7)*

484

700

1.4 (1.4–1.5)*

607

941

1.5 (1.5–1.6)*

  1. #Standardized incidence ratios (SIR) for chronic disease in the newly sick-listed sample are shown. If the SIR is 1.0 the incidence among the newly sick-listed equals that of the general population sample. A significant difference (*) between the two samples is observed when the 95% confidence interval does not include 1.0.
Back to article page

BMC Public Health

ISSN: 1471-2458

Contact us